🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📖We are delighted to share a new publication presenting the findings of an EORTC survey on the resectability of stage III #NSCLC, which is part of the Delphi consensus project. The visual shows the survey agreement results. 👉doi.org/10.1016/j.lung… #CancerResearch #LungCancer

Great dinner with old and new friends at #ELCC25 Julia Rotow MD Dana-Farber's Lowe Center for Thoracic Oncology Laura Mezquita

Great to be included in the 2025 EORTC Mentoring and Career Development Program! The event got off to a great start with two days of in-person meeting that just concluded. Amazing initiative!

Narjust Florez, MD, FASCO #TumorBoardTuesday Dr. Estela Rodriguez #FlorezLab Eric K. Singhi, MD Isabel Preeshagul Stephen V Liu, MD Jill Feldman Young Lung Cancer Initiative LUNGevity Foundation Oncogene Cancer Research Dana-Farber's Lowe Center for Thoracic Oncology Balazs Halmos Misty Dawn Shields EGFR Resisters Nathan A. Pennell MD, PhD, FASCO gilberto lopes Oncology Brothers Arthi Sridhar Coral Olazagasti, MD Ana I. Velázquez Mañana, MD, MSc, FASCO Biagio Ricciuti, MD, PhD Arianna Marinello, MD Jordi Remon Mariana Brandao Lodovica Zullo Stephanie Saw Gustave Roussy Alessandro Di Federico Federica Pecci 5/X #TumorBoardTuesday 👨🏽‍🏫Mini Tweetorial 2👨🏽‍🏫 5/X 🎯 What do recent IO trials tell us about outcomes in early-stage NSCLC? 📉 All perioperative and adjuvant trials show EFS/DFS benefit with IO vs chemo alone 🔍 Here’s how hazard ratios compare for: 🟣 EFS (neoadj/periop trials)

Marco Tagliamento doing the kickoff of the EORTC #LungCancer Group Spring meeting at the beautiful city of #Genova 😍 Super excited for these 3-days meeting, starting today with the Young and Early Career Investigators Day, dedicated to training & education in clinical trias 🫁

Fino a domani ospiteremo il meeting dell’EORTC Lung Cancer Group: appuntamento strategico per rafforzare la rete europea della ricerca contro il tumore del polmone, che causa oltre 35.000 decessi ogni anno in Italia. Focus su ricerca, innovazione e nuove cure. Marco Tagliamento

It was a pleasure to contribute to such a fertile scientific discussion. Thanks Marco Tagliamento EORTC for the invitation! God save academic research!

Three formidable days dedicated to clinical research, collaboration and mentoring come to an end. It was a pleasure to host the EORTC Lung Cancer Group in Genova!🇮🇹 Anne-Marie Dingemans Benjamin Besse Jordi Remon Mariana Brandao Corinne Faivre-Finn Roberto Ferrara Matthias Guckenberger OncoAlert

📢 Call for Cases open! Join the 9th #CCI4EU course: "Developing research skills for young researchers". - Pre-recorded: by 31 July 2025 - Live: 25 September 2025 👉 Submit now: bit.ly/4cFxTiQ Organisation of European Cancer Institutes #ESOncology

Meetings in a Box Highlights dai principali congressi in oncologia ROAD TO... ASCO 2025 A cura di Marco Tagliamento , Genova La guida per non perdere le presentazioni più importanti discusse al congresso. Guarda ora su: ow.ly/Pip950VZ5Fl #Oncologia #Oncology #ASCO #ASCO25

📢ESOncology masterclass for young investigators! 🎥Contents soon available online + submit a study proposal by July 6!💡 We will discuss live on Sept 25 the 4 selected! 👉e-eso.net/courses/25CC9#… Matteo Lambertini, MD PhD Evandro de Azambuja, MD, PhD Benjamin Besse Antonio Marra Saskia Litiere OncoAlert

Join us at #ASCO25 tomorrow to discuss the efficacy of immune checkpoint inhibitors in patients with CNS metastases from solid tumors, a group often overlooked in clinical trials Soraia Lobo-Martins Diogo Martins Branco Evandro de Azambuja, MD, PhD Marco Tagliamento Elisa Agostinetto Eva Blondeaux Matteo Lambertini, MD PhD

Kicking off the day with the #OncoAlert5k at #ASCO25 ! Thanks Gil, great initiative as usual! Gil Morgan, MD Francesca Poggio OncoAlert ASCO

#ASCO25 Julia Rotow MD Dana-Farber elegantly presents the case for #osimertinib Monotherapy over combination strategies (FLAURA2, MARIPOSA) ▶️ Reserving combination for higher risk pts ▶️ Maximixing each therapy in sequential approach ▶️ Shared decision w patients EGFR Resisters

The engagement continues at #ASCO25 with Francesca Poggio and Marco Tagliamento from Ospedale San Martino Genova 🇮🇹 leading experts in breast and lung cancer, respectively! 👩‍⚕️🧑‍⚕️ Great discussions and exciting perspectives at #Booth12041 ✨ #ISLB ASCO #UNIGE Roberto Borea, MD

Always enjoy discussing the data and the science at the poster sessions. Great to see so many friends at #ASCO25 Sanjay Popat Jorge Alatorre Alexander Nasser Hanna Clarissa Mathias Marco Tagliamento Kelly Meza, MD Hossein Borghaei, DO Thomas Wu

This discussion of SERENA-6 trial was excellent. #ASCO25 This doesn’t feel practice changing to me.

It should not be in the presenters' role to conclude by saying whether a study is or is not practice changing. This is the job of the impartial discussant. #ASCO25 ASCO

Α big lung cancer family comes together every year and ASCO united by a common passion and vision and of course by our unique host Marina Garassino !! #ASCO25

#ASCO25 most enjoyable one so far! Delighted to present our research, plan collabs and most importantly celebrate milestones with friends. Discussing data with people real-time in the congress beats listening online any day. Now time to combat jet lag 😵‍💫